Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 SEP 14 ... Mr. Wright. Valortim , which is being co-developed by PharmAthene and Medarex, Inc., is a fully human monoclonal antibody designed to protect against and treat ...
2009 SEP 14 ... of companies such as Human Genome Sciences and Targacept and the marquee acquisition of Medarex by Bristol-Myers Squibb. In addition, we did see an IPO get out the door in August. ...
2009 NOV 2 ... our String of Pearls strategy and I'm pleased to see that we've rapidly integrated Medarex into our R&D organization. Since formally acquiring...
2009 SEP 14 ... announced that it has completed its previously announced $2.4 billion acquisition of Medarex, Inc. (NASDAQ: MEDX) ("Medarex"). As a result of the ...
2009 SEP 7 ... subsidiary, Puma Acquisition Corporation, for all outstanding shares of common stock of Medarex, Inc. (NASDAQ: MEDX) ("Medarex") expired at midnight ...
2009 SEP 14 ... that the depositary for its tender offer for all the outstanding common stock of Medarex has advised that, as of the expiration of the subsequent offering period, shareholders ...
2009 NOV 23 ... agreements. Compugen's current collaborations include Bayer Schering Pharma, Biosite, Medarex, Inc., Merck & Co., Inc., Merck Serono, Ortho-Clinical Diagnostics (a Johnson & Johnson ...
2009 SEP 14 ... at various companies including Dow Chemical, Tanox Inc., Pharming Healthcare Inc., Medarex, Human Genome Sciences and Roche with increasing responsibilities. Jeffrey has 25 ...
2009 SEP 21 ... His expertise is acknowledged by companies such as Pfizer, Amgen, Myriad Genetics, Medarex, and Biogen Idec. Aaron Whiteman, CEO of GENova, says, "We are delighted ...
2009 SEP 21 ... are tremendous." Licensing to companies such as Pfizer, Amgen, Myriad Genetics, Medarex, and Biogen Idec could prove to be extremely lucrative in the short and long term. ...
2009 AUG 31 ... such as Pfizer (NYSE: PFE), Amgen (NASDAQ:AMGN), Myriad Genetics (NASDAQ:MYGN), Medarex (NASDAQ: MEDX), and Biogen Idec (NASDAQ:BIIB). Mr. Whiteman said, "I am ...
2009 NOV 23 ... advance its pipeline." Mr. Pien was the Chairman of the Board and CEO of Medarex, Inc. from 2007 to its acquisition by Bristol-Myers Squibb Company in September 2009. ...
2009 AUG 31 ... Mr. Middlekauff most recently served as senior vice president, strategic planning at Medarex, Inc. Before that, he was senior vice president, general counsel and secretary at...
